2018 Disease Radiation 
AuntMinnie
SEPTEMBER 11, 2024
PET, CT, and MRI use for assessing coronary artery disease increased in Medicare patients from 2018 to 2022, while SPECT and stress echocardiography declined over the same period, researchers have reported. Taken together, these findings call for efforts to address barriers impeding wider uptake of PET,” the group wrote.
AuntMinnie
JANUARY 31, 2024
To that end, the researchers analyzed the use of the technique from a trial they first launched in 2018. The researchers included a total of 178 with salvage RT plans available who had enrolled in the trial between September 2018 and August 2020 at UCLA and the University of California, San Francisco.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
MARCH 15, 2024
However, increased longevity has brought on a troubling rise in chronic disease, diminishing the quality of life later in life. A 2018 study from the U.S. Centers for Disease Control and Prevention (CDC) found that more than a quarter of U.S. Mark Crockett, MD, chief medical officer at TeleDaaS.
Imaging Technology
DECEMBER 20, 2023
While neuromelanin was first described in the 19 th century, researchers have elucidated its possible role as a biomarker for neurological disorders such as Parkinson’s disease in the last two decades. Cassidy, “it allows us to obtain potentially useful adjunctive information about many other diseases such as Alzheimer’s disease, and PTSD.”
Imaging Technology
OCTOBER 3, 2023
2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA. sites were treated with GammaTile, a treatment that provides immediate radiation where it is needed most after brain tumor removal surgery. Amsbaugh; Catherine S. Kim (2023).
AuntMinnie
JUNE 6, 2024
Owing primarily to its noise reduction capabilities, DLR has repeatedly been shown to sharply lower radiation dose while maintaining image quality. Around 2018, however, development efforts for DLR began to pick up. Accordingly, commercial and research activity has accelerated.
AuntMinnie
MARCH 26, 2024
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
Expert insights. Personalized for you.
89 
Let's personalize your content